Journal
JOURNAL OF IMMUNOLOGY
Volume 199, Issue 5, Pages 1805-1816Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1700515
Keywords
-
Categories
Funding
- National Institutes of Health [1R01AI113270-01A1]
- Searle Funds at the Chicago Community Trust
Ask authors/readers for more resources
IFN-gamma is essential for control of Mycobacterium tuberculosis infection in vitro and in vivo. However, the mechanisms by which IFN-gamma controls infection remain only partially understood. One of the crucial IFN-gamma target genes required for control of M. tuberculosis is inducible NO synthase (iNOS). Although NO produced by iNOS is thought to have direct bactericidal activity against M. tuberculosis, the role of NO as a signaling molecule has been poorly characterized in the context M. tuberculosis infection. In this study, we found that iNOS broadly regulates the macrophage transcriptome during M. tuberculosis infection, activating antimicrobial pathways while also limiting inflammatory cytokine production. The transcription factor hypoxia inducible factor-1 alpha (HIF-1 alpha) was recently shown to be critical for IFN-gamma-mediated control of M. tuberculosis infection. We found that HIF-1 alpha function requires NO production, and that HIF-1 alpha and iNOS are linked by a positive feedback loop that amplifies macrophage activation. Furthermore, we found that NO inhibits NF-kappa B activity to prevent hyperinflammatory responses. Thus, NO activates robust microbicidal programs while also limiting damaging inflammation. IFN-gamma signaling must carefully calibrate an effective immune response that does not cause excessive tissue damage, and this study identifies NO as a key player in establishing this balance during M. tuberculosis infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available